I liked that letter along with the update on the sublingual tablet. I could see them implementing the RS upon the announcement of a successful trial outcome of the tablet. So the RS could be implemented in Q4 with an announcement of sales with the tablet. Just my thoughts.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links